Ribomic (TSE:4591) EBIT per Share: 円-24.03 (TTM As of Mar. 2026)


TSE:4591 Ribomic Inc TSE:4591
25 GF Score
Price 円64.00
! 3 Warning Signs
View Full Analysis

What is Ribomic EBIT per Share?

Ribomic TSE:4591 +1.59% 25 EBIT per Share is 円-24.03 as of Mar. 2026. GuruFocus rates TSE:4591 with a GF Score™ of 25/100. The stock has 3 warning signs investors should review. Among 1,179 Biotechnology companies, Ribomic ranks better than 61.92% on this metric.

Ribomic's EBIT per Share for the six months ended in Mar. 2026 was 円-12.32. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was 円-24.03.

During the past 3 years, the average EBIT per Share Growth Rate was 24.90% per year. During the past 5 years, the average EBIT per Share Growth Rate was 17.30% per year. During the past 10 years, the average EBIT per Share Growth Rate was 7.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Ribomic's EBIT per Share or its related term are showing as below:

TSE:4591' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -17.8   Med: 1.3   Max: 25.2
Current: 24.9

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Ribomic was 25.20% per year. The lowest was -17.80% per year. And the median was 1.30% per year.

TSE:4591's 3-Year EBIT Growth Rate is ranked better than
61.92% of 1179 companies
in the Biotechnology industry
Industry Median: 15.6 vs TSE:4591: 24.90

Ribomic's EBIT for the six months ended in Mar. 2026 was 円-668.90 Mil.

Ribomic  (TSE:4591) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Ribomic EBIT per Share Related Terms

Ribomic EBIT per Share Historical Data

* Premium members only.

The historical data trend for Ribomic's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ribomic EBIT per Share Chart

Ribomic Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBIT per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -62.20 -57.41 -31.27 -25.99 -24.32

Ribomic Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -14.97 -13.40 -12.07 -11.71 -12.32
TSE:4591
25GF Score
Ribomic Inc TSE:4591
EBIT per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ribomic EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Ribomic's EBIT per Share for the fiscal year that ended in Mar. 2026 is calculated as

EBIT per Share(A: Mar. 2026 )
=EBIT/Shares Outstanding (Diluted Average)
=-1207.132/49.646
=-24.31

Ribomic's EBIT per Share for the quarter that ended in Mar. 2026 is calculated as

EBIT per Share(Q: Mar. 2026 )
=EBIT/Shares Outstanding (Diluted Average)
=-668.903/54.309
=-12.32

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円-24.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT per Share →
What does a EBIT per Share of 円-24.03 mean?
Ribomic (TSE:4591) has a EBIT per Share of 円-24.03 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Ribomic and its competitors. According to the industry distribution chart, Ribomic ranks #449 out of 1179 companies in the Biotechnology industry, placing it in the top 38.1%.
Is Ribomic's EBIT per Share too high?
Ribomic's current EBIT per Share is 円-24.03. Based on the distribution chart, Ribomic ranks #449 out of 1179 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Ribomic has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Ribomic's EBIT per Share compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Ribomic ranks #449 out of 1179 companies for EBIT per Share. This puts Ribomic in the upper half of its industry. The industry median EBIT per Share is 15.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Biotechnology company?
The median EBIT per Share among Biotechnology companies is 15.60, based on 1,179 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Ribomic and its competitors. For the Biotechnology industry, the median EBIT per Share is 15.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ribomic's current EBIT per Share is 円-24.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ribomic stock overvalued right now?
Ribomic (TSE:4591) has a current EBIT per Share of 円-24.03. The current EBIT per Share is 円-24.03. Ribomic's overall GF Score™ is 25/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Ribomic (TSE:4591), the current EBIT per Share is 円-24.03 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ribomic Business Description

Address 3-16-13 Usui Building, Shirokanedai, Minato-ku, Tokyo, JPN, 108-0071
Ribomic Inc is a biopharmaceutical venture company based in Tokyo. The company is developing molecular targeted pharmaceutical drugs using RNA aptamers with its unique and advanced platform technologies, the RiboART System.
25GF Score

Get the complete analysis for TSE:4591

EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円64.00
Price